EQ

EQ

USD

Equillium Inc. Common Stock

$0.386+0.035 (9.940%)

Real-time Price

Healthcare
Biotechnology
United States

Price Chart

Loading Chart...

Key Metrics

Market Metrics
Company Fundamentals
Trading Stats

Market Metrics

Open

$0.351

High

$0.390

Low

$0.351

Volume

0.22M

Company Fundamentals

Market Cap

13.8M

Industry

Biotechnology

Country

United States

Trading Stats

Avg Volume

0.36M

Exchange

NCM

Currency

USD

52-Week Range

Low $0.34Current $0.386High $1.5

Related News

Analyst Upgrades

Leerink Partners Downgrades Equillium to Market Perform, Lowers Price Target to $1

Leerink Partners analyst Thomas Smith downgrades Equillium from Outperform to Market Perform and lowers the price target from $3 to $1.

View more
Leerink Partners Downgrades Equillium to Market Perform, Lowers Price Target to $1
BusinessWire

Equillium Announces Results of the Phase 3 EQUATOR Study of Itolizumab in First-Line Treatment of Patients with Acute Graft-Versus-Host Disease

Treatment with itolizumab did not improve complete or overall response rates at Day 29 Itolizumab achieved statistical significance in multiple secondary endpoints demonstrating compelling clinical benefit in

View more
Equillium Announces Results of the Phase 3 EQUATOR Study of Itolizumab in First-Line Treatment of Patients with Acute Graft-Versus-Host Disease
BusinessWire

Equillium Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate and Clinical Highlights

Announced topline data from the Phase 3 EQUATOR study in first-line acute graft-versus-host disease Breakthrough Therapy designation and meeting request to discuss potential for Accelerated Approval submitted to FDA,

View more
Equillium Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate and Clinical Highlights